MannKind | MNKD - Net Income


MannKind reported $668K in Net Income for its fiscal quarter ending in June of 2025.





Net Income Change Date
Adma Biologics USD 36.43M 2.21M Sep/2025
Dynavax Technologies USD 18.72M 114.82M Jun/2025
Eli Lilly USD 6.64B 1.05B Dec/2025
Halozyme Therapeutics USD 175.22M 10.06M Sep/2025
Insmed USD -370.02M 48.34M Sep/2025
MacroGenics USD 16.82M 53.07M Sep/2025
MannKind USD 668K 12.49M Jun/2025
Merck USD 2.96B 2.82B Dec/2025
Novo Nordisk DKK 4.03B 25.01B Jun/2025
Pfizer USD -1.65B 5.19B Dec/2025
Sanofi EUR -801M 3.6B Dec/2025
Xencor USD -6.03M 24.8M Sep/2025